In BRCA2-deficient cells, including certain types of breast cancer, RAD52 substitutes for the missing BRCA2 by recruiting RAD51 to the site of DNA breaks, suggesting that BRCA2 and RAD52 play very similar roles in the HDR pathway [36]. Here, RAD52 is linked to breast carcinoma.